We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Type
- ARTG (88)
- Cancellation by sponsor (27)
- Prescription medicine registration (19)
- Australian public assessment report (AusPar) (11)
- Section 14, TGO91 consent (3)
- Designation or determination (2)
- Prescription medicine decision summary (2)
- Prescription medicine evaluation (2)
- Cancellation or suspension (1)
Sponsor content
155 result(s) found, displaying 81 to 90
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NERVODERM lidocaine (lignocaine) 5% w/w dermal patch.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Safinamide
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Bulk Quadrivalent Influenza Vaccine (split virion, inactivated).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AFLURIA QUAD - Inactivated Quadrivalent Influenza vaccine (split virion), 60 mcg HA, Suspension for injection, pre-filled syringe with attached needle.
-
Prescription medicine registrationActive ingredients: influenza virus haemagglutinin.
-
Designation or determinationPriority review
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Influenza virus haemagglutinin
-
Australian public assessment report (AusPar)Australian public assessment report for Peramivir
-
Prescription medicine registrationActive ingredients: safinamide mesilate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PALEXIA SR tapentadol (as hydrochloride) 25 mg sustained release tablet blister pack.